Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07293117 · ClinicalTrials.gov registry record · NA

Evaluating Heart & Soil's Lifeblood on Iron and Energy Levels

A NA study of Energy, sponsored by Efforia.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT07293117: Recruiting NA study of Energy, sponsored by Efforia.

NCT07293117 is a NA study of Energy that is actively recruiting participants, run by Efforia. The registered enrollment target is 100 participants, below the 851-participant average among 7 other Energy trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07293117, a NA study of Energy, is actively recruiting participants, sponsored by Efforia.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

This study explores how Heart \& Soil's Lifeblood impacts iron levels and energy.

Primary Outcome

The Fatigue Perception and Impact Survey (FPIS) is a specialized questionnaire developed to evaluate the presence, severity, and impact of fatigue on an individual's life. Comprising a series of questions, the survey aims to capture both the subjective experience of fatigue and its consequences across various domains, such as physical, emotional, and social aspects. This tool is commonly used in clinical settings to assess fatigue in patients with various medical conditions, including chronic il

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Heart & Soil Lifeblood

Study Locations (1)

New York

  • Efforia - New York

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2025-09-09
Est. Completion 2026-09-09
Phase NA
Efforia

19 total trials

What NCT07293117 shows while recruiting

NCT07293117 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 851-participant average among 7 other Energy trials with a reported enrollment target (88% lower).

The record links to 1 condition, with Energy appearing as the primary indexed condition, and to 1 intervention - of which Heart & Soil Lifeblood is the first listed.

NCT07293117 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT07293117 about?

NCT07293117 is a clinical study titled "Evaluating Heart & Soil's Lifeblood on Iron and Energy Levels". This study explores how Heart \& Soil's Lifeblood impacts iron levels and energy.

What is the current status of trial NCT07293117?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-09-09. Estimated completion is 2026-09-09.

What conditions does trial NCT07293117 study?

This clinical trial studies the following conditions: Energy.

What interventions are being tested in trial NCT07293117?

The interventions under investigation include: Heart & Soil Lifeblood (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT07293117?

This trial is sponsored by Efforia, which has 19 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07293117 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Energy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07293117, the US trial registry maintained by the National Library of Medicine. NCT07293117 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.